ADS was initially exploited in the discovery of androgen receptor (AR) modulators based on scaffolds with no previously annotated AR activity (Figure 2).9 AR is a nuclear receptor which acts as a transcription regulator, crucial for the expression and development of male sexual characteristics; mutations of the AR have been associated with prostate cancer and androgen sensitivity syndrome.10 This evidence concerns the gene AR and prostate cancer.